Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Ubiquitination on Nonlysine Residues by a Viral E3 Ubiquitin Ligase
Ken Cadwell and
Laurent Coscoy*
Ubiquitination controls a broad range of cellular functions.The last step of the ubiquitination pathway is regulated byenzyme type 3 (E3) ubiquitin ligases. E3 enzymes are responsiblefor substrate specificity and catalyze the formation of an isopeptidebond between a lysine residue of the substrate (or the N terminusof the substrate) and ubiquitin. MIR1 and MIR2 are two E3 ubiquitinligases encoded by Kaposi's sarcomaassociated herpesvirusthat mediate the ubiquitination of major histocompatibilitycomplex class I (MHC I) molecules and subsequent internalization.Here, we found that MIR1, but not MIR2, promoted down-regulationof MHC I molecules lacking lysine residues in their intracytoplasmicdomain. In the presence of MIR1, these MHC I molecules wereubiquitinated, and their association with ubiquitin was sensitiveto ß2-mercaptoethanol, unlike lysine-ubiquitin bonds.This form of ubiquitination required a cysteine residue in theintracytoplasmic tail of MHC I molecules. An MHC I moleculecontaining a single cysteine residue in an artificial glycineand alanine intracytoplasmic domain was endocytosed and degradedin the presence of MIR1. Thus, ubiquitination can occur on proteinslacking accessible lysines or an accessible N terminus.
Department of Molecular and Cell Biology, 142 Life Sciences Addition Room 3200, Berkeley, CA 94720, USA.
* To whom correspondence should be addressed. E-mail: lcoscoy{at}berkeley.edu
Molecular Mechanism of BST2/Tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-Associated Herpesvirus.
M. Mansouri, K. Viswanathan, J. L. Douglas, J. Hines, J. Gustin, A. V. Moses, and K. Fruh (2009)
J. Virol.
83, 9672-9681
|Abstract »|Full Text »|PDF »
Functional Modulation of Dendritic Cells and Macrophages by Japanese Encephalitis Virus through MyD88 Adaptor Molecule-Dependent and -Independent Pathways.
A. G. Aleyas, J. A. George, Y. W. Han, M. M. Rahman, S. J. Kim, S. B. Han, B. S. Kim, K. Kim, and S. K. Eo (2009)
J. Immunol.
183, 2462-2474
|Abstract »|Full Text »|PDF »
LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor.
N. Zelcer, C. Hong, R. Boyadjian, and P. Tontonoz (2009)
Science
325, 100-104
|Abstract »|Full Text »|PDF »
Human Immunodeficiency Virus Type 1 Nef Protein Targets CD4 to the Multivesicular Body Pathway.
L. L. P. daSilva, R. Sougrat, P. V. Burgos, K. Janvier, R. Mattera, and J. S. Bonifacino (2009)
J. Virol.
83, 6578-6590
|Abstract »|Full Text »|PDF »
Adapter-mediated Substrate Selection for Endoplasmic Reticulum-associated Degradation.
K. Corcoran, X. Wang, and L. Lybarger (2009)
J. Biol. Chem.
284, 17475-17487
|Abstract »|Full Text »|PDF »
Polyubiquitination by HECT E3s and the Determinants of Chain Type Specificity.
Ubiquitylation on Canonical and Non-canonical Sites Targets the Transcription Factor Neurogenin for Ubiquitin-mediated Proteolysis.
J. M. D. Vosper, G. S. McDowell, C. J. Hindley, C. S. Fiore-Heriche, R. Kucerova, I. Horan, and A. Philpott (2009)
J. Biol. Chem.
284, 15458-15468
|Abstract »|Full Text »|PDF »
Properties of the Ubiquitin-Pex5p Thiol Ester Conjugate.
C. P. Grou, A. F. Carvalho, M. P. Pinto, S. J. Huybrechts, C. Sa-Miranda, M. Fransen, and J. E. Azevedo (2009)
J. Biol. Chem.
284, 10504-10513
|Abstract »|Full Text »|PDF »
Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin.
H. Wang, A. Matsuzawa, S. A. Brown, J. Zhou, C. S. Guy, P.-H. Tseng, K. Forbes, T. P. Nicholson, P. W. Sheppard, H. Hacker, et al. (2008)
PNAS
105, 20197-20202
|Abstract »|Full Text »|PDF »
The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system.
R. Sadeh, K. Breitschopf, B. Bercovich, M. Zoabi, Y. Kravtsova-Ivantsiv, D. Kornitzer, A. Schwartz, and A. Ciechanover (2008)
PNAS
105, 15690-15695
|Abstract »|Full Text »|PDF »
Remodeling of Endothelial Adherens Junctions by Kaposi's Sarcoma-Associated Herpesvirus.
M. Mansouri, P. P. Rose, A. V. Moses, and K. Fruh (2008)
J. Virol.
82, 9615-9628
|Abstract »|Full Text »|PDF »
The Varicellovirus UL49.5 Protein Blocks the Transporter Associated with Antigen Processing (TAP) by Inhibiting Essential Conformational Transitions in the 6+6 Transmembrane TAP Core Complex.
M. C. Verweij, D. Koppers-Lalic, S. Loch, F. Klauschies, H. de la Salle, E. Quinten, P. J. Lehner, A. Mulder, M. R. Knittler, R. Tampe, et al. (2008)
J. Immunol.
181, 4894-4907
|Abstract »|Full Text »|PDF »
Members of the E2D (UbcH5) Family Mediate the Ubiquitination of the Conserved Cysteine of Pex5p, the Peroxisomal Import Receptor.
C. P. Grou, A. F. Carvalho, M. P. Pinto, S. Wiese, H. Piechura, H. E. Meyer, B. Warscheid, C. Sa-Miranda, and J. E. Azevedo (2008)
J. Biol. Chem.
283, 14190-14197
|Abstract »|Full Text »|PDF »
APOBEC3G Is Degraded by the Proteasomal Pathway in a Vif-dependent Manner without Being Polyubiquitylated.
Y. Dang, L. M. Siew, and Y.-H. Zheng (2008)
J. Biol. Chem.
283, 13124-13131
|Abstract »|Full Text »|PDF »
The Specificities of Kaposi's Sarcoma-Associated Herpesvirus-Encoded E3 Ubiquitin Ligases Are Determined by the Positions of Lysine or Cysteine Residues within the Intracytoplasmic Domains of Their Targets.
Activation of CXCR4 Triggers Ubiquitination and Down-regulation of Major Histocompatibility Complex Class I (MHC-I) on Epithelioid Carcinoma HeLa Cells.
Z. Wang, L. Zhang, A. Qiao, K. Watson, J. Zhang, and G.-H. Fan (2008)
J. Biol. Chem.
283, 3951-3959
|Abstract »|Full Text »|PDF »
Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.
M. Thomas, J. M. Boname, S. Field, S. Nejentsev, M. Salio, V. Cerundolo, M. Wills, and P. J. Lehner (2008)
PNAS
105, 1656-1661
|Abstract »|Full Text »|PDF »
Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment.
S. W.G. Tait, E. de Vries, C. Maas, A. M. Keller, C. S. D'Santos, and J. Borst (2007)
J. Cell Biol.
179, 1453-1466
|Abstract »|Full Text »|PDF »
Dislocation of an Endoplasmic Reticulum Membrane Glycoprotein Involves the Formation of Partially Dislocated Ubiquitinated Polypeptides.
Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.
M. Mansouri, J. Douglas, P. P. Rose, K. Gouveia, G. Thomas, R. E. Means, A. V. Moses, and K. Fruh (2006)
Blood
108, 1932-1940
|Abstract »|Full Text »|PDF »
A Novel Family of Membrane-Bound E3 Ubiquitin Ligases.
M. Ohmura-Hoshino, E. Goto, Y. Matsuki, M. Aoki, M. Mito, M. Uematsu, H. Hotta, and S. Ishido (2006)
J. Biochem.
140, 147-154
|Abstract »|Full Text »|PDF »
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.
S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn (2006)
J. Gen. Virol.
87, 1781-1804
|Abstract »|Full Text »|PDF »
Inhibition of MHC Class II Expression and Immune Responses by c-MIR.
M. Ohmura-Hoshino, Y. Matsuki, M. Aoki, E. Goto, M. Mito, M. Uematsu, T. Kakiuchi, H. Hotta, and S. Ishido (2006)
J. Immunol.
177, 341-354
|Abstract »|Full Text »|PDF »
The Viral E3 Ubiquitin Ligase mK3 Uses the Derlin/p97 Endoplasmic Reticulum-associated Degradation Pathway to Mediate Down-regulation of Major Histocompatibility Complex Class I Proteins.
X. Wang, Y. Ye, W. Lencer, and T. H. Hansen (2006)
J. Biol. Chem.
281, 8636-8644
|Abstract »|Full Text »|PDF »
A Bacterial Inhibitor of Host Programmed Cell Death Defenses Is an E3 Ubiquitin Ligase.
R. Janjusevic, R. B. Abramovitch, G. B. Martin, and C. E. Stebbins (2006)
Science
311, 222-226
|Abstract »|Full Text »|PDF »
Viral strategies for evading antiviral cellular immune responses of the host.
A. Iannello, O. Debbeche, E. Martin, L. H. Attalah, S. Samarani, and A. Ahmad (2006)
J. Leukoc. Biol.
79, 16-35
|Abstract »|Full Text »|PDF »